Time-dependent associations between dietary intake, disease activity, and cardiovascular risk markers in rheumatoid arthritis: insights from a controlled comparative study
This controlled comparative study demonstrates that specific dietary components, such as nut and seed intake, exhibit time-dependent associations with cardiovascular risk markers and disease activity in rheumatoid arthritis patients before and after initiating DMARD therapy, highlighting the need for targeted dietary interventions.
Original paper licensed under CC BY 4.0 (https://creativecommons.org/licenses/by/4.0/). This is an AI-generated explanation of the paper below. It is not written or endorsed by the authors. For technical accuracy, refer to the original paper. Read full disclaimer
Rheumatoid arthritis is a condition where the body's immune system mistakenly attacks the joints, causing persistent pain and swelling. While this inflammation is most visible in the hands and knees, it does not stay there. It travels through the bloodstream, irritating the lining of blood vessels and accelerating the hardening of arteries, which significantly raises the risk of heart disease. For decades, doctors have focused on stopping the immune attack with powerful medications, but a growing question has emerged: could what patients eat also play a role in calming this internal fire and protecting their hearts? The answer is not simple, because the body changes as treatment begins. What a person eats before taking medicine might affect their health differently than what they eat months later, once the inflammation is under control. Understanding how diet interacts with disease activity over time is crucial, because it could reveal specific foods that help or hurt patients at different stages of their journey.
A team of researchers in Australia set out to map these changing relationships. They followed sixty-two adults who had just been diagnosed with rheumatoid arthritis and had not yet started any treatment. The scientists wanted to see if the food these people ate was linked to how active their disease was and how stiff their arteries had become. They measured specific signs of inflammation in the blood and calculated a disease activity score that combines pain, swelling, and blood test results. They also checked the stiffness of the arteries and blood pressure in the center of the body, which are key indicators of heart risk. The participants were divided into two groups based on the medication their doctors prescribed: one group started taking methotrexate, and the other started taking sulfasalazine. The researchers checked these patients at three distinct moments: right before they took their first pill, one month after starting treatment, and six months later.
At the very beginning, before any medication had a chance to work, the researchers found a clear link between diet and heart health. People who ate more nuts and seeds had more flexible arteries and lower central blood pressure. This connection was strong and independent of the patient's age, weight, or sex. However, at this early stage, what they ate did not seem to change how active their arthritis was. The inflammation was so high that it likely masked any subtle effects of food on the disease itself. One month after starting treatment, the picture was quiet. The researchers could not find any significant links between what the patients ate and their disease activity or heart markers. This period appeared to be a transition phase where the body was adjusting to the new medication, and the signals from diet were not yet detectable.
By the six-month mark, the story had changed significantly. The inflammation was better controlled, and the researchers could finally see how specific foods influenced the disease and the heart. They discovered that eating more maltose, a type of sugar found in certain carbohydrates, was linked to higher disease activity scores. Conversely, eating more chloride, a mineral found in salt, was linked to lower disease activity. On the heart front, the benefits of nuts and seeds remained steady; those who ate them continued to have more flexible arteries. However, a new and surprising pattern emerged. People who consumed more total folate, a B vitamin, had stiffer arteries. This seemed odd because folate is usually considered good for heart health. The researchers suggested this might not be because folate itself was harmful, but because patients taking methotrexate are often prescribed extra folate supplements to reduce side effects. Therefore, high folate intake might simply be a sign that a patient was taking a higher dose of medication or had a more complex treatment plan, rather than a direct cause of stiffer arteries. Additionally, drinking more non-alcoholic beverages, which likely included sugary or artificially sweetened drinks, was linked to higher central blood pressure at this stage.
The study concludes that the relationship between diet and rheumatoid arthritis is not static; it shifts as treatment takes hold. Before treatment, a diet rich in nuts and seeds appears to offer a stable shield for the arteries. Once treatment begins and the disease is calmed, the influence of other foods becomes visible. Refined sugars and certain beverages may start to drive up disease activity and blood pressure, while the protective effect of nuts and seeds endures. The researchers emphasize that these findings are specific to the timing of the measurements. The data suggests that dietary advice for rheumatoid arthritis patients should not be a one-size-fits-all rule but should evolve alongside their treatment. While the study does not prove that changing the diet will cure the disease, it provides strong evidence that specific foods are tied to how the disease behaves and how the heart functions at different times. The consistent benefit of nuts and seeds stands out as a reliable target for patients to include in their daily lives to support both their joints and their hearts.
Drowning in papers in your field?
Get daily digests of the most novel papers matching your research keywords — with technical summaries, in your language.